Patanjali on Tuesday launched ‘Coronil and Swasari’, what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 per cent favourable results during clinical trials on affected patients, at Patanjali Yogpeeth here.
Patanjali Ayurvedic Medicines has launched ‘Coronil’ anti-COVID tablets to combat and prevent the spread of the deadly coronavirus. Researched by Patanjali Research Institute with clinical trails held at NIMS University, Jaipur, the anti-corona tablet was launched by Baba Ramdev on Tuesday. Clinical control trials were carried out adhering to standardized protocols of drug discovery to evaluate its efficacy, the company said. Within the span of 3 to 15 days, all the corona positive patients transformed into negative ones without observing any mortality, the company’s release about the tablet claims.
“The whole country and the world was waiting for medicine or vaccine for corona. We are proud to announce that the first Ayurvedic, clinically controlled trial based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research Centre and NIMS,” Yoga Guru Ramdev said at the press conference here adding that it has shown “100 per cent recovery rate within 3-7 days.”
“We are launching COVID medicines Coronil and Swasari today. We conducted two trials of these, first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this 280 patients were included and 100 per cent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted,” he added.